I was diagnosed March 2025 with NSCLC Adenocarcinoma with RET gene mutation. A 35 mm tumour in my left Bronchi and METs in my back and Brain. I started Selpercatinib and within a week my breathing returned to normal. First scan showed shrinkage to 15mm after 3 months. The Brain Mets were zapped with Stereotactic surgery. The problem with Selpercatinib is the fatigue ,loss of libido , slight skin rash and heightened sensitivity around my lips . I have remained fit and aged 71.
I am in a very small group of people with this condition and therapy , majority of patients appear to be women . No national statistics appear to exist for this treatment and it is early days . I would be very interested to hear from others in this category.
Whatever cancer throws your way, we’re right there with you.
We’re here to provide physical, financial and emotional support.
© Macmillan Cancer Support 2026 © Macmillan Cancer Support, registered charity in England and Wales (261017), Scotland (SC039907) and the Isle of Man (604). Also operating in Northern Ireland. A company limited by guarantee, registered in England and Wales company number 2400969. Isle of Man company number 4694F. Registered office: 3rd Floor, Bronze Building, The Forge, 105 Sumner Street, London, SE1 9HZ. VAT no: 668265007